{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:43:36Z","timestamp":1778910216016,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":874,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Prinses Beatrix Fonds","award":["OP07-08"],"award-info":[{"award-number":["OP07-08"]}]},{"DOI":"10.13039\/501100001826","name":"ZonMw-the Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","award":["152001005"],"award-info":[{"award-number":["152001005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.nmd.2010.11.016","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T04:30:48Z","timestamp":1293078648000},"page":"232-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers"],"prefix":"10.1016","volume":"21","author":[{"given":"Linda E.M.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juna M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold J.J.","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2010.11.016_b0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (Acid Maltase) deficiency","author":"Hirschorn","year":"2001"},{"issue":"9646","key":"10.1016\/j.nmd.2010.11.016_b0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"issue":"Pt 3","key":"10.1016\/j.nmd.2010.11.016_b0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2010.11.016_b0020","series-title":"Myology","first-page":"1559","article-title":"Acid maltase deficiency","author":"Engel","year":"2004"},{"issue":"4","key":"10.1016\/j.nmd.2010.11.016_b0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2010.11.016_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/auto.2984","article-title":"Autophagy and lysosomes in Pompe disease","volume":"2","author":"Fukuda","year":"2006","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.nmd.2010.11.016_b0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0925-4439(02)00229-6","article-title":"Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II","volume":"1637","author":"Hesselink","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.nmd.2010.11.016_b0040","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2010.11.016_b0045","first-page":"S42","article-title":"Autophagy in skeletal muscle: implications for Pompe disease","volume":"47","author":"Shea","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.nmd.2010.11.016_b0050","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: a prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.nmd.2010.11.016_b0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/brain\/93.3.599","article-title":"Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies","volume":"93","author":"Engel","year":"1970","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nmd.2010.11.016_b0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.410010314","article-title":"The adult form of acid maltase (alpha-1, 4-glucosidase) deficiency","volume":"1","author":"Karpati","year":"1977","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2010.11.016_b0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jnnp.47.2.213","article-title":"Myopathy due to juvenile acid maltase deficiency affecting exclusively the type I fibres","volume":"47","author":"Papapetropoulos","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.nmd.2010.11.016_b0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1978.00500270057013","article-title":"Selective vacuolar myopathy with atrophy of type II fibers. Occurrence in a childhood case of acid maltase deficiency","volume":"35","author":"Horoupian","year":"1978","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2010.11.016_b0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.nmd.2010.11.016_b0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ymgme.2007.04.018","article-title":"Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease","volume":"91","author":"Hawes","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.nmd.2010.11.016_b0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/mus.20896","article-title":"Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease","volume":"37","author":"Drost","year":"2008","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.nmd.2010.11.016_b0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2010.11.016_b0095","article-title":"Fatigue in neuromuscular disorders: focus on Guillain\u2013Barre syndrome, Pompe disease","author":"de Vries","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.nmd.2010.11.016_b0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jbiomech.2004.05.040","article-title":"Effects of non-contractile inclusions on mechanical performance of skeletal muscle","volume":"38","author":"Drost","year":"2005","journal-title":"J Biomech"},{"issue":"9413","key":"10.1016\/j.nmd.2010.11.016_b0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2010.11.016_b0110","series-title":"Exercise physiology","first-page":"314","article-title":"Skeletal muscle: structure and function","author":"McArdle","year":"1996"},{"key":"10.1016\/j.nmd.2010.11.016_b0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1249\/00003677-199600240-00016","article-title":"Muscle mechanics: adaptations with exercise-training","volume":"24","author":"Fitts","year":"1996","journal-title":"Exerc Sport Sci Rev"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2010.11.016_b0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610006929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610006929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:59:05Z","timestamp":1760774345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896610006929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0960896610006929"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2010.11.016","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2010.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}